The clinical impact of using complex molecular profiling strategies in routine oncology practice.

about

The clinical impact of using complex molecular profiling strategies in routine oncology practice.

Item

http://www.wikidata.org/entity/Q55009579

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The clinical impact of using c ...... in routine oncology practice.

@en

The clinical impact of using c ...... in routine oncology practice.

@nl

type

Item

label

The clinical impact of using c ...... in routine oncology practice.

@en

The clinical impact of using c ...... in routine oncology practice.

@nl

prefLabel

The clinical impact of using c ...... in routine oncology practice.

@en

The clinical impact of using c ...... in routine oncology practice.

@nl

P1154

2-s2.0-85045532618

http://www.w3.org/2001/XMLSchema#string

P1433

Oncotarget

P1476

The clinical impact of using c ...... in routine oncology practice.

@en

P2093

Abdul Rahman El Kinge

http://www.w3.org/2001/XMLSchema#string

Ana Finzel

http://www.w3.org/2001/XMLSchema#string

Angel Garcia

http://www.w3.org/2001/XMLSchema#string

Anthony Kong

http://www.w3.org/2001/XMLSchema#string

Carlos Camps

http://www.w3.org/2001/XMLSchema#string

Carlos Regonesi

http://www.w3.org/2001/XMLSchema#string

Christos Mikropoulos

http://www.w3.org/2001/XMLSchema#string

Fadi El Karak

http://www.w3.org/2001/XMLSchema#string

Gregori Ghitti

http://www.w3.org/2001/XMLSchema#string

Hady Ghanem

http://www.w3.org/2001/XMLSchema#string

P2860

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice

Circumventing cancer drug resistance in the era of personalized medicine.

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

A Systematic Review of Predictions of Survival in Palliative Care: How Accurate Are Clinicians and Who Are the Experts?

Next-Generation Sequencing to Guide Clinical Trials.

Targeted cancer therapies in the twenty-first century: lessons from imatinib.

P304

20282-20293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24757

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guy Berchem

Timo Joensuu

P5530

37873752

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103396334

http://www.w3.org/2001/XMLSchema#string

P698

29755651

http://www.w3.org/2001/XMLSchema#string

P932

5945513

http://www.w3.org/2001/XMLSchema#string

P953

136561